CoChat

Polytherapy in Bipolar Disorder

The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.

Abstract

Bipolar disorder is a life-long condition that is associated with frequent recurrence/relapse of symptoms. Although putative mood stabilisers, such as lithium, are considered to improve the natural course of bipolar disorder, complete long-term remission is rarely achieved. In order to effectively control mood symptoms and to reduce relapse, clinicians often use polypharmacy to treat patients with bipolar disorder. In this article, we examine the recent literature on treatment strategies in bipolar disorder to determine if combination treatments provide additional benefit over monotherapy for the management of various phases of bipolar disorder. The evidence suggests that for acute mania a combination of lithium or valproate and an atypical antipsychotic is the most effective approach, with approximately 20% more patients responding to the combination than to monotherapy with any antimanic agent. Few studies have examined the use of combination therapy in comparison to monotherapy for bipolar depression. The limited evidence suggests that lithium plus an antidepressant appears to be more effective than lithium alone in those with lower serum lithium concentrations. Similarly, the combination of olanzapine plus fluoxetine is more effective than olanzapine alone. There is consensus that antidepressant monotherapy is not appropriate because of concerns of a manic switch, but monotherapy with lithium or lamotrigine may be adequate for mild to moderate bipolar depression. For main…

Overview

Integrity signals

Registry

Crossref · 10.2165/00023210-200620010-00003

Cites

104 of 104 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 104 references

Research works printed but not linked: 13

  1. McElroy, 1996, J Clin Psychiatry, 57, 142
  2. Chou, 1991, J Clin Psychopharmacol, 11, 3
  3. Segal, 1998, Clin Neuropharmacol, 21, 176
  4. Granneman, 1996, J Clin Psychiatry, 57, 204
  5. Small, 1995, Psychopharmacol Bull, 31, 265
  6. Schaff, 1993, J Clin Psychiatry, 54, 380
  7. Chaudhry, 1983, J Clin Psychiatry, 44, 30
  8. Onady, 1989, J Clin Psychopharmacol, 9, 387
  9. Burgess, 2001, Cochrane Database Syst Rev, &NA;, CD003013
  10. Sachs, 1994, J Clin Psychiatry, 55, 391
  11. Post, 2001, Bipolar Disord, 3, 259, 10.1034/j.1399-5618.2001.30505.x · doi:10.1034/j.1399-5618.2001.30505.x
  12. Small, 1990, Psychopharmacol Bull, 26, 25
  13. Macritchie, 2001, Cochrane Database Syst Rev, &NA;, CD003196

Cited by

See all 100

Metadata

Authors
Lin, D., Mok, H., & Yatham, L. N.
Affiliations
University of British Columbia (CA)
Corresponding author
Yatham, Lakshmi N
Venue
CNS Drugs
Published
2006
Volume
20
Issue
1
Pages
29-42
ISSN
1172-7047 (ISSN-L)
OpenAlex
W1981711813
Cited by
91
References
101
Citations by year
2025: 1 · 2024: 1 · 2023: 4 · 2022: 2 · 2021: 1 · 2020: 4 · 2019: 6 · 2018: 8 · 2017: 3 · 2016: 4 · 2015: 5 · 2014: 8 · 2013: 6 · 2012: 2
FWCI
1.24
Type
journal article
Language
en
Open access
closed
Locations
  • CNS Drugs (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Eli Lilly and Company
  • H. Lundbeck A/S
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
bipolar disorder, polypharmacy, combination therapy, monotherapy, lithium, valproic acid, atypical antipsychotics, olanzapine, fluoxetine, lamotrigine, bipolar depression, manic switch, depressive relapse prevention, acute mania
MeSH terms
Antidepressive Agents, Bipolar Disorder, Drug Therapy, Combination, Humans, Antipsychotic Agents, Practice Guidelines as Topic, Antimanic Agents, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Polytherapy in Bipolar Disorder. https://app.cochat.ai/papers/10.2165/00023210-200620010-00003
The paper
Lin, D., Mok, H., & Yatham, L. N. (2006). Polytherapy in Bipolar Disorder. CNS Drugs. https://doi.org/10.2165/00023210-200620010-00003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.